📰 Human Use News
Page 130 - Human Use News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Human Use. Real-time updates on events, politics, business and more.
June 28, 2022
The EMA CHMP has recommended granting approval for AstraZeneca and Merck’s Lynparza (olaparib) for high-risk early breast cancer patients.
June 28, 2022
Europe Daily News, the latest policy and legal developments in the European Union
June 28, 2022
Nexviadyme® (avalglucosidase alfa) approved by European Commission as a potential new standard of care for the treatment of Pompe Disease Approved for the...
June 28, 2022
The Janus kinase inhibitor is already approved for the treatment of active ankylosing spondylitis in the European Union.
June 27, 2022
LONDON (dpa-AFX) - AstraZeneca Plc. (AZN.L, AZN) and Merck & Co Inc.'s (MRK) Lynparza or olaparib has been recommended for marketing authorization in the European Union as monotherapy or in combination
June 27, 2022
Investegate announcements from AstraZeneca PLC, Enhertu recommended for breast cancer EU approval
June 27, 2022
Investegate announcements from AstraZeneca PLC, Lynparza recommended in EU for early breast cancer
June 27, 2022
LONDON (dpa-AFX) - AstraZeneca Plc (AZN.L, AZN) and Daiichi Sankyo's Enhertu or trastuzumab deruxtecan has been recommended for approval in the European Union by the Committee for Medicinal Products
June 27, 2022
/PRNewswire/ -- AbbVie (NYSE: ABBV) today announced the European Medicines Agencys (EMA) Committee for Medicinal Products for Human Use (CHMP) recommended the...
June 27, 2022
(RTTNews) - AstraZeneca Plc (AZN.L, AZN) and Daiichi Sankyos Enhertu or trastuzumab deruxtecan has been recommended for approval in the European ...